SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:umu-14831"
 

Sökning: onr:"swepub:oai:DiVA.org:umu-14831" > A single bolus of a...

A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing.

Näsström, Birgit (författare)
Umeå universitet,Institutionen för folkhälsa och klinisk medicin
Stegmayr, Bernd (författare)
Umeå universitet,Institutionen för folkhälsa och klinisk medicin
Gupta, Jitendra (författare)
Umeå universitet,Institutionen för klinisk vetenskap,Fysiologisk kemi
visa fler...
Olivecrona, Gunilla (författare)
Umeå universitet,Fysiologisk kemi
Olivecrona, Thomas (författare)
Umeå universitet,Fysiologisk kemi
visa färre...
 (creator_code:org_t)
2005-03-29
2005
Engelska.
Ingår i: Nephrology, Dialysis and Transplantation. - : Oxford University Press (OUP). - 0931-0509 .- 1460-2385. ; 20:6, s. 1172-1179
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • BACKGROUND: Low molecular weight heparins (LMWH) are increasingly used during haemodialysis (HD) to prevent clotting in the extracorporeal devices. It has been suggested that LMWH release endothelial-bound lipoprotein lipase (LPL) less efficiently than unfractionated heparin (UFH) does and thereby cause less disturbance of lipid metabolism. Evidence from in vitro studies and from animal experiments indicate, however, that both types of heparin preparations have the same ability to release endothelial LPL, but LMWH are less effective in preventing uptake and degradation of LPL in the liver. Model studies in humans indicate that LMWH cause as much depletion of LPL stores and impaired lipolysis of triglyceride (TG)-rich lipoproteins as UFH does. METHODS: Two anticoagulant regimes based on present clinical practice were compared in nine HD patients. UFH was administered as a primed infusion, whereas the LMWH (dalteparin) was given only as a single bolus pre-dialysis. Blood was sampled regularly for LPL activity and TG. RESULTS: LPL activity in blood was significantly lower during the dialysis with dalteparin. To explore the remaining activity at the endothelium, a bolus of UFH was given after 3 h of dialysis. The bolus brought out about the same amount of LPL, regardless of whether UFH or dalteparin had been used during dialysis. The increase in TG was significantly higher during dialysis with dalteparin. CONCLUSIONS: This study indicates that a single bolus of dalteparin pre-dialysis interferes with the LPL system as much as, or more than an infusion of UFH does.

Nyckelord

Adult
Aged
Aged; 80 and over
Anticoagulants/administration & dosage/*pharmacology
Dalteparin/administration & dosage/*pharmacology
Female
Heparin/pharmacology
Humans
Lipoprotein Lipase/*blood
Male
Middle Aged
Renal Dialysis
Triglycerides/blood
MEDICINE
MEDICIN

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy